Joshi SR - Search Results

1

Evidence-based recommendations for insulin intensification strategies after basal insulin in type 2 diabetes.

Ghosh S, Unnikrishnan AG, Saboo B, Kesavadev J, Aravind SR, Bajaj S, Rajput R, Seshadri K, Verma N, Gupta A, Makkar BM, Saikia M, Kale S, Damodaran S, Dengra A, Eashwar TKM, Maheshwari A, Pendsey S, Phatak SR, Sharma SK, Singh SK, Ramachandran A, Zargar AH, Joshi SR, Sadikot SM. Ghosh S, et al. Among authors: joshi sr. Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S507-S521. doi: 10.1016/j.dsx.2017.03.045. Epub 2017 Apr 5. Diabetes Metab Syndr. 2017. PMID: 28433618 Review.

2

The role of oral semaglutide in managing type 2 diabetes in Indian clinical settings: Addressing the unmet needs.

Joshi SR, Rajput R, Chowdhury S, Singh AK, Bantwal G, Das AK, Unnikrishnan AG, Saboo BD, Kesavadev J, Ghosal S, Mohan V. Joshi SR, et al. Diabetes Metab Syndr. 2022 Jun;16(6):102508. doi: 10.1016/j.dsx.2022.102508. Epub 2022 May 23. Diabetes Metab Syndr. 2022. PMID: 35653929 Review.

3

Improvement of glycemic control with addition of insulin detemir to existing antidiabetic therapy: a sub-group analysis of A1chieve observational study.

Kesavadev J, Joshi SR. Kesavadev J, et al. Among authors: joshi sr. J Assoc Physicians India. 2013 Jan;61(1 Suppl):28-30. J Assoc Physicians India. 2013. PMID: 24482985

4

Time-in-range and frequency of continuous glucose monitoring: Recommendations for South Asia.

Kesavadev J, Misra A, Saboo B, Agarwal S, Sosale A, Joshi SR, Hussain A, Somasundaram N, Basit A, Choudhary P, Soegondo S. Kesavadev J, et al. Among authors: joshi sr. Diabetes Metab Syndr. 2022 Jan;16(1):102345. doi: 10.1016/j.dsx.2021.102345. Epub 2021 Nov 22. Diabetes Metab Syndr. 2022. PMID: 34920199 Review.

5

Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment.

Talaviya PA, Saboo BD, Joshi SR, Padhiyar JN, Chandarana HK, Shah SJ, Vyas CK, Shah AN. Talaviya PA, et al. Among authors: joshi sr. Diabetes Metab Syndr. 2013 Apr-Jun;7(2):68-71. doi: 10.1016/j.dsx.2013.02.032. Epub 2013 Mar 30. Diabetes Metab Syndr. 2013. PMID: 23680243 Clinical Trial.

6

Acarbose plus metformin fixed-dose combination in the management of type 2 diabetes.

Joshi SR, Ramachandran A, Chadha M, Chatterjee S, Rathod R, Kalra S. Joshi SR, et al. Expert Opin Pharmacother. 2014 Aug;15(11):1611-20. doi: 10.1517/14656566.2014.932771. Epub 2014 Jun 25. Expert Opin Pharmacother. 2014. PMID: 24963542 Review.

7

Retrospective comparison of voglibose or acarbose as an add-on therapy to sulfonylureas in Western Indian patients with uncontrolled overweight/obese type 2 diabetes.

Talaviya PA, Saboo BD, Dodiya HG, Rao SK, Joshi SR, Modh VB, Ghadiya SV. Talaviya PA, et al. Among authors: joshi sr. Diabetes Metab Syndr. 2016 Apr-Jun;10(2):88-91. doi: 10.1016/j.dsx.2015.09.021. Epub 2015 Nov 25. Diabetes Metab Syndr. 2016. PMID: 26777258

8

Remogliflozin Etabonate in the Treatment of Type 2 Diabetes: Design, Development, and Place in Therapy.

Mohan V, Mithal A, Joshi SR, Aravind SR, Chowdhury S. Mohan V, et al. Among authors: joshi sr. Drug Des Devel Ther. 2020 Jun 24;14:2487-2501. doi: 10.2147/DDDT.S221093. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32612352 Free PMC article. Review.

9

New and Unique Clusters of Type 2 Diabetes Identified in Indians.

Anjana RM, Pradeepa R, Unnikrishnan R, Tiwaskar M, Aravind SR, Saboo B, Joshi SR, Mohan V. Anjana RM, et al. Among authors: joshi sr. J Assoc Physicians India. 2021 Feb;69(2):58-61. J Assoc Physicians India. 2021. PMID: 33527813

10

Prescribing Patterns and Response to Antihyperglycemic Agents Among Novel Clusters of Type 2 Diabetes in Asian Indians.

Anjana RM, Siddiqui MK, Jebarani S, Vignesh MA, Kamal Raj N, Unnikrishnan R, Pradeepa R, Panikar VK, Kesavadev J, Saboo B, Gupta S, Sosale AR, Seshadri KG, Deshpande N, Chawla M, Chawla P, Das S, Behera M, Chawla R, Nigam A, Gupta A, Kovil R, Joshi SR, Agarwal S, Bajaj S, Pearson ER, Doney ASF, Palmer CNA, Mohan V. Anjana RM, et al. Among authors: joshi sr. Diabetes Technol Ther. 2022 Mar;24(3):190-200. doi: 10.1089/dia.2021.0277. Epub 2022 Jan 5. Diabetes Technol Ther. 2022. PMID: 34609928

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

500 results

Search Page

Filters